Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Intas B2BIntas B2B
VS
Bristol Myers SquibbBristol Myers Squibb
Intas B2B

Intas B2B

Barcelona, ES

Last Update: 21/03/2026

View Profile
Between 750 and 799
https://intasb2b.com
755/1000Fair

Intas Pharmaceuticals Ltd. is a vertically integrated global company, leading in the development, manufacturing and marketing of pharmaceutical formulations, including Generics, Biosimilars and Added Value Medicines. It has been growing at about 13% CAGR over the last...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0
Bristol Myers Squibb

Bristol Myers Squibb

3401 Princeton Pike, Lawrence Township, 08648, US

Last Update: 09/09/2026

View Profile
Between 750 and 799
http://www.bms.com
794/1000Fair

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds i...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:38,258
Subsidiaries:1
12-month incidents
0
Known data breaches
0
Attack type number
2

Compliance Ranges Comparison

Based On Specific Ai Models Category
Intas B2B

Intas B2B

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Bristol Myers Squibb

Bristol Myers Squibb

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Intas B2B in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Bristol Myers Squibb in 2026.

Incidents

Incident History - Intas B2B (X = Date, Y = Severity)

Intas B2B cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Bristol Myers Squibb (X = Date, Y = Severity)

Bristol Myers Squibb cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Intas B2B

Intas B2B

Incidents
No explicit notable incidents reported.
Bristol Myers Squibb

Bristol Myers Squibb

Incidents
🔒 Incident : Cyber Attack
BRI533080525
🔒 Incident : Ransomware
ERT18610523
🔒 Incident : Ransomware
IQV125614222

FAQ

Between Intas B2B company and Bristol Myers Squibb company, which one has the best AI Cybersecurity Score ?
Between Intas B2B company and Bristol Myers Squibb company, which one has experienced more cyber incidents in the past ?
Between Intas B2B company and Bristol Myers Squibb company, which one has experienced more cyber incidents this year ?
Between Intas B2B company and Bristol Myers Squibb company, which one has experienced at least one ransomware attack ?
Between Intas B2B company and Bristol Myers Squibb company, which one has experienced at least one data breach ?
Between Intas B2B company and Bristol Myers Squibb company, which one has experienced at least one targeted cyberattack ?
Between Intas B2B company and Bristol Myers Squibb company, which one has experienced at least one vulnerability ?
Between Intas B2B company and Bristol Myers Squibb company, which one holds the most compliance certifications ?
Between Intas B2B company and Bristol Myers Squibb company, which one holds the fewest compliance certifications ?
Between Intas B2B company and Bristol Myers Squibb company, which one has the most subsidiaries ?
Between Intas B2B company and Bristol Myers Squibb company, which one has the largest number of employees ?
Between Intas B2B and Bristol Myers Squibb, which company holds both SOC 2 Type 1 certifications ?
Between Intas B2B and Bristol Myers Squibb, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Intas B2B or Bristol Myers Squibb ?
Which company is PCI DSS compliant - Intas B2B or Bristol Myers Squibb ?
Between Intas B2B and Bristol Myers Squibb, which company complies with HIPAA regulations for healthcare data ?
Between Intas B2B and Bristol Myers Squibb, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-91201
SUMMARY

DocsGPT through 0.20.0 posts OAuth connector session tokens to a wildcard target origin in the callback-status endpoint without validating sender origin. Attackers can obtain session tokens and provider account emails by acting as window.opener during OAuth authorization, then use tokens to disconnect victims' cloud storage connectors.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 5.4)
CVSS3
Base Score: 5.4
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
2.5
EXPLOITABILITY
2.8
CVE-2026-91200
SUMMARY

DevSpace through 6.3.21 fails to reject parent-directory segments in tar entry names from the in-pod sync stream. Attackers operating a malicious container can stream tar entries with traversal sequences to write arbitrary files on the developer workstation, enabling code execution.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-91199
SUMMARY

Refly through 1.1.0 contains a server-side request forgery vulnerability in the POST /v1/misc/scrape endpoint that fetches caller-supplied URLs without validating the scheme, host, or resolved address. Authenticated attackers can make the backend issue requests to loopback, private, and link-local addresses including cloud metadata services to read page titles and descriptions of internal resources.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 5)
CVSS3
Base Score: 5.0
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:N/A:N
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:N/SC:L/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.1
CVE-2026-91198
SUMMARY

GrowthBook through 5.0.1 returns unredacted fact table definitions including raw warehouse SQL in payloads served by unauthenticated public report and experiment endpoints. Attackers with knowledge of a publicly shared report or experiment identifier can read internal data warehouse query text, schema, table names, filter values and datasource identifiers.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 5.3)
CVSS3
Base Score: 5.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.9
CVE-2026-91197
SUMMARY

Flowable flowable-engine through 8.0.0 contains an XML external entity injection vulnerability in ProcessDiagramLayoutFactory.parseXml() that fails to disable external entity resolution when parsing deployed BPMN resources. Attackers with process deployment privileges can embed DOCTYPE declarations with external entities in BPMN files to read arbitrary local files or trigger requests to internal network endpoints when diagram layout is computed.

PUBLISHED
Date2026-09-14
UPDATED
Date2026-09-14
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
CVSS4
Base Score: 7.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
2.8